Effects of bevacizumab on retinal function in isolated vertebrate retina

BACKGROUND: Bevacizumab (Avastin) is a recombinant protein that targets vascular endothelial growth factor (VEGF). In vitro, bevacizumab inhibits VEGF induced cell proliferation and tissue factor production. Abnormal angiogenesis involving VEGF is a central event during the development of choroidal...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lüke, M, Warga, M, Ziemssen, F, Gelisken, F, Grisanti, S, Schneider, T, Lüke, C, Partsch, M, Bartz‐Schmidt, K U, Szurman, P
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Group 2006
Ämnen:
Laboratory Science - Extended Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857377/
https://ncbi.nlm.nih.gov/pubmed/16754646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.094995
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk